HR9077Referred to Committee

To direct the Director of the National Institutes of Health and the Secretary of Health and Human Services to evaluate hormone variability and hormone testing, respectively, in women with respect to perimenopause.

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-05-29
Introduced
0
Cosponsors
HR
Type

Sponsor

Hillary J. Scholten
Hillary J. Scholten
Democrat · MI · Representative
Votes with party: 93.4% (527 recorded votes)

Full profile: /officials/S001221

Source: Congress.gov · FEC

Cosponsors (0)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2026-05-29

Source: Congress.gov

Committee Activity

Currently in

Plain-English Summary

The federal government would study how hormone levels change in women going through perimenopause (the years leading up to menopause) and evaluate the accuracy and usefulness of hormone tests during this time. The National Institutes of Health and the Department of Health and Human Services would work together to understand these hormonal changes better and determine which tests doctors should use to help women during this life stage. This research could help doctors provide better care and treatment options for women experiencing perimenopause symptoms.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Full bill text is not yet cached locally.